Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The ID1 protein, an inhibitor of basic helix-loop-helix transcription factors, has been involved in multiple cellular processes including cell cycle regulation, apoptosis, and angiogenesis. To evaluate the importance of ID1 in malignant melanoma, tumour cell expression was examined by immunohistochemistry in 119 cases of nodular melanoma using tissue microarray technique, and related to multiple tumour markers including proliferation, p16 expression, angiogenesis and patient survival. Strong ID1 expression was significantly associated with increased tumour thickness, and significantly reduced survival. Also, increased ID1 was associated with loss of thrombospondin-1 (TSP-1) expression, a known inhibitor of angiogenesis, and increased intensity of ephrin-A1 and its receptor EPHA2. Presence of BRAF mutations was related to strong ID1 expression, but there was no relationship with p16 protein expression. Further, no significant correlation was found between ID1 and microvessel density. In conclusion, our study supports a significant role of the ID1 protein in melanoma progression and patient prognosis. The absence of correlation with p16 protein expression and angiogenesis suggests that other regulatory pathways and mechanisms might be influenced by ID1 in melanomas. An inverse relation between ID1 and TSP-1 expression support an important role of ID1 in the regulation of this complex multitarget protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Upregulation of EphA2 occurs in several cancers such as melanoma [157], ovarian [158, 159], prostate [160, 161], lung [162, 163], and breast [164, 165] cancer.”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,099
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · cited 2×
“Id proteins were shown to influence VEGF-dependent mobilisation of circulating endothelial cells and endothelial precursor cells from the bone marrow (Lyden et al, 2001).”
BackgroundId1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts
Lyden, D., Young, A. Z., Zagzag, D., Yan, W., Gerald, W., O'Reilly, R., Bader, B. L., Hynes, R. O., Zhuang, Y., Manova, K., et al. (1999) · Nature · doi:10.1038/44334 · Cited by 922
Aas, T., Børresen, A.-L., Geisler, S., Smith-Sørensen, B., Johnsen, H., Varhaug, J. E., Akslen, L. A., & Lønning, P. E. (1996) · Nature Medicine · doi:10.1038/nm0796-811 · Cited by 736
Self-citationRegulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733
Norušis, M. J. (1994) · Medical Entomology and Zoology · Cited by 699
Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence
Ohtani, N., Zebedee, Z., Huot, T. J. G., Stinson, J. A., Sugimoto, M., Ohashi, Y., Sharrocks, A. D., Peters, G., & Hara, E. (2001) · Nature · doi:10.1038/35059131 · Cited by 654 · cited 4×
“The specificity of both antibodies has been reported (Hollnagel et al, 1999; Nickoloff et al, 2000; Ohtani et al, 2001;Czuwara-Ladykowska et al, 2002; Chambers et al, 2003).”
BackgroundInfluentialId Genes Are Direct Targets of Bone Morphogenetic Protein Induction in Embryonic Stem Cells
Hollnagel, A., Oehlmann, V., Heymer, J., Rüther, U., & Nordheim, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19838 · Cited by 527
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
Rocco, J. W., & Sidransky, D. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5149 · Cited by 470
Id helix—loop—helix proteins in cell growth and differentiation
Norton, J. D., Deed, R. W., Craggs, G., & Sablitzky, F. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)80013-5 · Cited by 410
Cited by
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“Upregulation of EphA2 occurs in several cancers such as melanoma [157] , ovarian [158, 159] , prostate [160, 161] , lung [162, 163] , and breast [164, 165] cancer.”
BackgroundIsenberg, J. S., Martin-Manso, G., Maxhimer, J. B., & Roberts, D. D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2561 · Cited by 305
Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
Rothberg, B. E. G., Bracken, M. B., & Rimm, D. L. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp038 · Cited by 180
Functional implication of BMP4 expression on angiogenesis in malignant melanoma
Rothhammer, T., Bataille, F., Spruss, T., Eissner, G., & Bosserhoff, A.-K. (2007) · Oncogene · doi:10.1038/sj.onc.1210182 · Cited by 162
Chang, P. N., Yap, W. N., Lee, D. T. W., Ling, M. T., Wong, Y. C., & Yap, Y. L. (2009) · Nutrition and Cancer · doi:10.1080/01635580802567166 · Cited by 93
Mern, D. S., Hoppe‐Seyler, K., Hoppe‐Seyler, F., Hasskarl, J., & Burwinkel, B. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0810-6 · Cited by 84
Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma
Yuen, H.-F., Chan, Y., Chan, K.-H., Chu, Y.-Y., Wong, M.-I., Law, S. Y.-K., Srivastava, G., Wang, X., Wang, X., & Chan, K.-W. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604035 · Cited by 72
Therapies using anti-angiogenic peptide mimetics of thrombospondin-1
Henkin, J., & Volpert, O. V. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.640319 · Cited by 65
Expression of Id-1 Is Regulated by MCAM/MUC18: A Missing Link in Melanoma Progression
Zigler, M., Villares, G. J., Dobroff, A. S., Wang, H., Huang, L., Braeuer, R. R., Kamiya, T., Melnikova, V. O., Song, R., Friedman, R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3555 · Cited by 55
Nair, R., Teo, W. S., Mittal, V., & Swarbrick, A. (2014) · Molecular Therapy · doi:10.1038/mt.2014.83 · Cited by 51
DJ-1 upregulates breast cancer cell invasion by repressing KLF17 expression
Ismail, I. A., Hs, K., Lee, H.-J., Jk, K., & Sh, H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.40 · Cited by 51
Tissue prognostic biomarkers in primary cutaneous melanoma
Mandalà, M., & Massi, D. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1526-x · Cited by 49
Lee, Y. S., Yoon, S., Yoon, H.-J., Lee, K., Yoon, H. K., Lee, J., & Song, C. W. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.05.019 · Cited by 42
Melanoma biomarkers: current status and vision for the future
Larson, A. R., Konat, E., & Alani, R. M. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1296 · Cited by 38
Hyaluronic acid-CD44 interactions promote BMP4/7-dependent Id1/3 expression in melanoma cells
Wu, R., Sedlmeier, G., Kyjacová, L., Schmaus, A., Philipp, J., Thiele, W., Garvalov, B. K., & Sleeman, J. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-33337-7 · Cited by 37
Zhang, X., Ling, M., Wong, Y. C., & Wang, X. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00400.x · Cited by 33
Ephrin Expression and Function in Cancer
McCarron, J. K., Stringer, B. W., Day, B. W., & Boyd, A. (2009) · Future Oncology · doi:10.2217/fon.09.146 · Cited by 29
Tada, K., Kawahara, K., Matsushita, S., Hashiguchi, T., Maruyama, I., & Kanekura, T. (2011) · Phytotherapy Research · doi:10.1002/ptr.3645 · Cited by 29
Id1 delays senescence of primary human melanocytes
Cummings, S. D., Ryu, B., Samuels, M. A., Yu, X., Meeker, A. K., Healey, M. A., & Alani, R. M. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20422 · Cited by 27
Id2 suppression of p15 counters TGF‐β‐mediated growth inhibition of melanoma cells
Schlegel, N. C., Eichhoff, O. M., Hemmi, S., Werner, S., Dummer, R., & Hoek, K. S. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00571.x · Cited by 25
Genome-wide Analysis of BP1 Transcriptional Targets in Breast Cancer Cell Line Hs578T
Song, Y., Dang, C., Fu, Y., Lian, Y., Hottel, J., Li, X., McCaffrey, T., & Fu, S. W. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.1 · Cited by 25
Mirea, M. A., Eckensperger, S., Hengstschläger, M., & Mikula, M. (2020) · Cancers · doi:10.3390/cancers12092508 · Cited by 23
Prognostic Value of Elevated SHIP2 Expression in Laryngeal Squamous Cell Carcinoma
Zhou, X., Liu, Y., & Tan, G. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.10.012 · Cited by 23
Yu, W., Scott, S. A., & Dong, W. ‐. (2008) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00499.x · Cited by 23
Luo, K., Wen, J., Xie, X., Fu, J., Luo, R.-Z., Wu, Q., & Hu, Y. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.01.102 · Cited by 22
Maw, M. K., Fujimoto, J., & Tamaya, T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604722 · Cited by 21
Coronella, J. A., Li, L., Johnson, K., Pirie-Shepherd, S. R., Roxas, G., & Levin, N. (2009) · PubMed · Cited by 21
Ephrin-A1 promotes the malignant progression of intestinal tumors in Apcmin/+ mice
Shi, L., Itoh, F., Itoh, S., Takahashi, S., Yamamoto, M. P., & Kato, M. (2008) · Oncogene · doi:10.1038/sj.onc.1210992 · Cited by 19
Inhibitor of DNA Binding-1 Overexpression in Prostate Cancer: Relevance to Tumor Differentiation
Yu, X., Xu, X., Han, B., & Zhou, R. (2008) · Pathology & Oncology Research · doi:10.1007/s12253-008-9096-y · Cited by 18
Cancer microenvironment and genomics: evolution in process
Leong, S. P. L., Witz, I. P., Sagi‐Assif, O., Izraely, S., Sleeman, J. P., Piening, B., Fox, B. A., Bifulco, C. B., Martini, R. N., Newman, L. A., et al. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10097-9 · Cited by 17
Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia.
Zhou, J., Yang, L., Zhu, X., Wen, X., Yang, J. C., Guo, H. Y., Chen, Q., Yao, D., Ma, J., Lin, J., et al. (2015) · PubMed Central · Cited by 17
Perivoliotis, K., Ntellas, P., Dadouli, K., Koutoukoglou, P., Ιωάννου, Μ., & Tepetes, K. (2017) · Journal of Skin Cancer · doi:10.1155/2017/2049140 · Cited by 16
Peres, J., Damerell, V., Chauhan, J. S., Popovic, A., Desprez, P., Galibert, M., Goding, C. R., & Prince, S. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.02.740 · Cited by 13
Healey, M. A., Deaton, S. L., Alder, J. K., Winnepenninckx, V. J. L., Casero, R. A., & Herman, J. G. (2010) · Epigenetics · doi:10.4161/epi.5.5.11929 · Cited by 13
Wang, L., Hu, H., Tian, F., Zhou, W., Zhou, S., & Wang, J. (2015) · PubMed Central · Cited by 8
Pocket protein function in melanocyte homeostasis and neoplasia
Tonks, I. D., Hayward, N. K., & Kay, G. F. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00321.x · Cited by 6
BMP-dependent oligoclonal cancer attractor state precedes neural crest fate in melanoma initiationPreprint
McConnell, A. M., Chassé, M. H., Noonan, H. R., Mito, J. K., Barbano, J., Weiskopf, E., Gosselink, I. F., Yang, S. P., Drake, K. D., Baron, C. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.22.618007 · Cited by 3
Sedlmeier, G., Al‐Rawi, V., Buchert, J., Yserentant, K., Rothley, M., Steshina, A., Gräßle, S., Wu, R., Hurrle, T., Richer, W., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000065 · Cited by 3
Molecular spectrum of pigmented skin lesions: from nevus to melanoma
Jiang, H. L., Wortsman, J., Matsuoka, L. Y., Granese, J., Carlson, J. A., Mihm, M. C., & Slominski, A. T. (2006) · Expert Review of Dermatology · doi:10.1586/17469872.1.5.679 · Cited by 2
Hu, Y., Luo, K., Wen, J., & Zhu, Z. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.09.04 · Cited by 2
ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein)
Castañón, E., & Bazo, I. G. (2013) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/48495 · Cited by 1
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Sachindra, S. (2018) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00024196 · Cited by 1
The new melanoma: a novel model for disease progression
Schlegel, N. C. (2008) · ETH Zürich Research Collection · doi:10.3929/ethz-a-005593522
Götz, L. S., Deo, A., Scherer, S. D., D’Antonio, L., Weber, H. T., Sedlmeier, G., Flores, L. P. T., Kaiser, U., Far, E., Raviv, Z., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.05.742008
DiVito, K. A. (2013) · DigitalGeorgetown (Georgetown University Library)
The role of platelets in vasculogenic mimicry
Martino, C. (2017) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Identifikation neuer Zielgene der Helix-Loop-Helix-Proteine der ID-Familie
Gutmann, A. F. (2011) · FreiDok plus (Universitätsbibliothek Freiburg)
Metadata
- Authors
- Straume, O., & Akslen, L. A.
- Affiliations
- Haukeland University Hospital (NO)
- Corresponding author
- Akslen, L A
- Venue
- British Journal of Cancer
- Published
- 2005-09-27
- Volume
- 93
- Issue
- 8
- Pages
- 933-938
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC2361652
- OpenAlex
- W2032702028
- Cited by
- 42
- References
- 40
- Citations by year
- 2024: 1 · 2021: 2 · 2020: 3 · 2018: 2 · 2017: 1 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 1
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Helse Vest
- Norges Forskningsråd
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- Id1, nodular melanoma, thrombospondin-1, ephrin-A1, EphA2, tumor thickness, patient survival, prognosis, BRAF mutation, p16, angiogenesis, microvessel density, tumor progression, bHLH transcription factors
- MeSH terms
- Cell Survival, Humans, Immunohistochemistry, Melanoma, Neovascularization, Pathologic, Prognosis, Skin Neoplasms, Biomarkers, Tumor, Up-Regulation, Disease-Free Survival, Thrombospondin 1, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Ephrin-A1, Ephrin-A2, Inhibitor of Differentiation Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.